Beam Therapeutics, Inc. (BEAM)
24.05
-0.51
(-2.08%)
USD |
NASDAQ |
Oct 23, 16:00
24.03
-0.02
(-0.08%)
After-Hours: 20:00
Beam Therapeutics Price : 24.05 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 24.00 | 24.14 | 23.24 | 24.05 | 1.596M |
| Oct 22, 2026 | 24.38 | 25.29 | 24.00 | 24.56 | 1.385M |
| Oct 21, 2026 | 24.83 | 25.20 | 24.50 | 24.84 | 1.168M |
| Oct 20, 2026 | 24.00 | 25.06 | 23.61 | 24.93 | 1.480M |
| Oct 19, 2026 | 23.88 | 24.38 | 23.50 | 24.19 | 1.317M |
| Oct 16, 2026 | 24.56 | 24.56 | 23.16 | 23.47 | 1.653M |
| Oct 15, 2026 | 23.51 | 24.98 | 23.20 | 24.73 | 1.780M |
| Oct 14, 2026 | 24.13 | 24.26 | 23.28 | 23.65 | 1.662M |
| Oct 13, 2026 | 24.88 | 24.93 | 24.08 | 24.43 | 1.668M |
| Oct 12, 2026 | 25.63 | 26.09 | 24.94 | 25.13 | 1.414M |
| Oct 09, 2026 | 24.72 | 26.22 | 24.55 | 25.70 | 1.802M |
| Oct 08, 2026 | 24.26 | 24.69 | 23.91 | 24.60 | 2.426M |
| Oct 07, 2026 | 24.64 | 25.37 | 24.45 | 24.77 | 2.343M |
| Oct 06, 2026 | 26.80 | 26.94 | 24.86 | 25.23 | 2.523M |
| Oct 05, 2026 | 24.48 | 26.04 | 23.83 | 25.67 | 2.002M |
| Oct 02, 2026 | 25.00 | 25.48 | 24.21 | 24.50 | 1.499M |
| Oct 01, 2026 | 24.24 | 24.98 | 23.96 | 24.39 | 1.695M |
| Sep 30, 2026 | 24.79 | 25.20 | 24.41 | 24.45 | 1.559M |
| Sep 29, 2026 | 23.88 | 24.76 | 23.88 | 24.52 | 1.638M |
| Sep 28, 2026 | 24.02 | 24.66 | 23.44 | 24.23 | 1.274M |
| Sep 25, 2026 | 24.97 | 24.97 | 23.75 | 24.27 | 1.221M |
| Sep 24, 2026 | 23.88 | 24.81 | 23.16 | 24.66 | 2.284M |
| Sep 23, 2026 | 25.75 | 26.24 | 24.22 | 24.37 | 1.900M |
| Sep 22, 2026 | 25.62 | 26.50 | 25.07 | 25.93 | 1.989M |
| Sep 21, 2026 | 25.45 | 25.66 | 24.83 | 25.26 | 1.704M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 11.21 |
| Twist Bioscience Corp. | 139.92 |
| Prime Medicine, Inc. | 3.67 |
| Sarepta Therapeutics, Inc. | 17.73 |
| Q32 Bio, Inc. | 8.65 |
Price Related Metrics
| PS Ratio | 15.99 |
| Price to Book Value | 2.327 |
| Earnings Yield | -3.58% |
| Market Cap | 2.484B |